Krishnappa Babu, Pradeep Raj
Aikat, Vikram
Di Martino, J. Matias
Chang, Zhuoqing
Perochon, Sam
Espinosa, Steven
Aiello, Rachel
L. H. Carpenter, Kimberly
Compton, Scott
Davis, Naomi
Eichner, Brian
Flowers, Jacqueline
Franz, Lauren
Dawson, Geraldine
Sapiro, Guillermo
Funding for this research was provided by:
NIH Autism Centers of Excellence Award (NICHD P50HD093074)
National Institute of Mental Health (NIMH R01MH121329)
Article History
Received: 27 October 2022
Accepted: 27 April 2023
First Online: 3 May 2023
Competing interests
: K.L.H.C., Z.C., S.E., G.D., and G.S. developed technology related to the app that has been licensed, and both they and Duke University have benefited financially. G.D. is on the Scientific Advisory Boards of Akili, Inc., Zynerba Pharmaceuticals, Inc., Nonverbal Learning Disability Project, and Tris Pharma, Inc., is a consultant to Apple Inc., Gerson Lehrman Group, and Guidepoint Global, LLC, and receives book royalties from Guilford Press and Springer Nature. G.D. and G.S. have invention disclosures and patent applications registered at the Duke Office of Licensing and Ventures. G.S. is affiliated with Apple Inc.; this work was done before and independently of that affiliation. P.R.K.B., V.A., J.M.D.M., Z.C., S.P., R.A., S.C., N.D., B.E., J.F., and L.F. do not have any competing interests.